Cooley M&A

MARCH 1, 2019

Even for a thriving business with a viable equity story, committed stakeholders and the right advisers, the final deal terms and valuation are typically guided by factors beyond a company’s control. Stock market forces also make the timing of an eventual outright exit and the final blended valuation of equity sales over time uncertain.

IPO 52

IPO Valuation M&A Business 52

Francine Way

JULY 8, 2017

Many of these causes have their equivalences to the reasons behind the sale of a company (also known as a divestiture): Liquidity: As the equity holding period matured, investors (private equity funds behind companies) will look to sell. Once a sale has been decided, the process to look for a new owner is pretty well established.

M&A 130

M&A Acquisitions Sale Investment 130

Cooley M&A

OCTOBER 29, 2020

is the increased frequency at which SPAC IPOs are occurring. As reflected in Chart 1 , 102 SPAC IPOs have been announced this year as of September 18, 2020—almost double the number of SPAC IPOs in all of last year (and more than double the number of SPAC IPOs in 2018). SPAC vs. IPO. Valuation Certainty.

M&A 52

M&A IPO Valuation Mergers and Acquisitions 52

Mergers and Inquisitions

JANUARY 24, 2024

They invest when companies already have revenue (like PE firms), but they do so by purchasing minority stakes , holding them, and selling in an IPO or M&A exit (like VC firms). Specifically, should we invest €60 million at a pre-money valuation of €1.2 multiple and 30% IRR? new shares get created).

Equities 105

Equities Valuation Financial Statement Financial Modeling 105

Razorpay

JULY 27, 2023

Investment banking is a branch of banking that organizes and enables large, complex financial transactions for businesses, like mergers, IPOs or underwriting. Investment Banking Services Initial Public Offering (IPO) When a privately-owned business wants to become a publicly traded company, it goes through an IPO , or Initial Public Offering.

Investment Banking 52

Investment Banking Bank Banking Investment 52

Wall Street Mojo

JANUARY 17, 2024

The investing activities comprise the long-term asset purchase or sale. Add to it all the incoming cash from various sources like cash sale of goods or services, proceeds from the sale of assets or investments, the funds acquired by the issue of shares or through bank loans, etc.

Accountant 98

Accountant Finance Finance Profitability 98

Sun Acquisitions

SEPTEMBER 16, 2024

Invest in strategic initiatives to boost your company’s performance and market position, ultimately increasing its valuation. Having well-documented processes in place not only streamlines operations but also instills confidence in potential buyers regarding the business’s sustainability post-sale.

Negotiation 59

Negotiation Business Sale Management 59

Solganick & Co.

MAY 13, 2024

Some of his firm’s notable M&A transactions include Accenture’s acquisition of Nexira, Pandera Systems merger with 66 Degrees, Waypoint Consulting’s sale to WIPFLI, Visual BI’s sale to ATOS, as well as Flagship Solutions Group’s merger with Data Storage Corp, and others within the technology sector.

M&A 40

M&A Investment Banking Mergers and Acquisitions Private Equity 40

Mergers and Inquisitions

SEPTEMBER 20, 2023

If you worked at a startup, how did you win more customers or partners in a sales or business development role? Technical Questions – You could get standard questions about accounting and valuation or VC-specific questions about cap tables, key metrics in your industry, or how to value startups.

Capital 59

Capital Valuation Investment Portfolio 59

Mergers and Inquisitions

OCTOBER 18, 2023

Investment Banking: Deals The basic difference is that in “investment banking” groups, such as technology , TMT , healthcare , or consumer retail , you work on various deal types: sell-side and buy-side M&A, leveraged buyouts, IPOs, follow-on offerings, and bond issuances. or debt offerings (investment-grade or high-yield bonds).

Investment Banking 59

Investment Banking Capital Market Recruitment Capital 59

Mergers and Inquisitions

MARCH 13, 2024

This style is about purchasing minority stakes in cash-flow-negative-but-high-growth companies that want to scale and eventually go public or sell (think: Uber or Airbnb before their IPOs). Valuations are high, the returns depend on future growth, and deals are for primary capital , i.e., new cash the business needs.

Private Equity 105

Private Equity Equities Capital Portfolio 105

Mergers and Inquisitions

JULY 12, 2023

They want a $2 million seed investment at a $20 million post-money valuation, meaning that we (the VCs) will own 10% if we invest. Here’s a summary of the different stages: Since the asking valuation is $20 million, we can reframe this case study as: “Could this company potentially reach 100x that valuation, or $2 billion?

Capital 52

Capital Valuation Boutique Bank 52

Software Equity Group

SEPTEMBER 17, 2024

C Corp for Software Companies Factor Impact Investor Appeal Tax Efficiency Ownership Flexibility M&A Potential C Corps are highly attractive to investors, particularly for those considering venture capital or IPO. C Corps are favorable for stock sales, making them ideal for larger exits.

M&A 52

M&A Corporation Stock Investors 52

Mergers and Inquisitions

MAY 24, 2023

They have their investment thesis and valuation, and the earnings announcement is the event that unlocks value… …but this is not what “event-driven” means in most cases. But if we’re wrong, and the spin-off doesn’t happen or gets done at a lower valuation, the parent company’s share price would fall by only 10%.”

Funds 64

Funds Investors Mergers and Acquisitions Mergers 64

The Deal

AUGUST 9, 2023

M&A is a central part of SymphonyAI’s growth strategy as the company prepares for a potential private placement and, eventually, an IPO. “We’re company focuses on retail, consumer goods, financial services, industrials and IT, and expects between $450 million to $500 million in sales this year.

M&A 40

M&A Private Equity Retail Financial Services 40

Focus Investment Banking

APRIL 14, 2024

Healthy competition for the top bakeries has increased valuations in recent years, with strong purchase price / cash flow (EBITDA) multiples. For bakery operators, pursuing a sale in today’s active M&A market offers many benefits from finding the right partner to help fuel growth to securing a promising future for loyal employees.

M&A 52

M&A Food Private Equity Manufacturing 52

Cooley M&A

JANUARY 23, 2024

Looming patent cliffs By 2030, more than 190 drugs will lose patent exclusivity , including 69 blockbuster drugs, putting at risk $236 billion in sales. Many buyers have adjusted their valuation expectations across the market accordingly, while the adoption of a “new normal” worldview catches hold more gradually on the sell side.

M&A 52

M&A Mergers and Acquisitions Acquisitions Pharmaceutical 52

Cooley M&A

JANUARY 25, 2023

Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. For example, the sale of Horizon Therapeutics to Amgen for approximately $28 billion was the third-largest all-cash transaction in the pharmaceutical sector in history.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Mergers and Inquisitions

APRIL 12, 2023

In regions like London and Hong Kong , ACs are used for investment banking , sales & trading , and other areas at banks and consulting firms. The questions resemble the ones you might find on the GMAT or the “mental math” questions common in sales & trading interviews. How much would it be worth?

Investment Banking 64

Investment Banking Bank Banking Investment 64

Cooley M&A

JANUARY 22, 2021

Divestitures, often achieved through asset sales, were also popular in 2020 as large pharmaceutical companies and biotechnology companies sought to divest noncore assets and focus on core businesses in the wake of economic uncertainty created by the pandemic. Earnouts Remain Popular – and Difficult.

M&A 40

M&A Mergers and Acquisitions Collaboration Mergers 40

Software Equity Group

MARCH 21, 2023

Minority investors aim to increase value and earn a return on their investment when your business undergoes additional transactions down the line, whether through additional capital raises, acquisition, or an initial public offering (IPO). In contrast, others are interested in liquidating 100% of shares in a sale and exiting the company.

Finance 52

Finance Finance Debt Equities 52

Mergers and Inquisitions

NOVEMBER 1, 2023

Mispriced Companies and Assets – Some mature healthcare firms trade at low valuation multiples , often because the market misunderstands their contracts, revenue, or track record. At the time of the deal, it was expected to grow sales at 3-5%: Remember that PE deals do not require “growth.” For example, in the U.S.,

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Cooley M&A

FEBRUARY 7, 2023

Companies lacking cash turned to M&A to provide liquidity, while companies with cash on hand were able to capitalize on depressed valuations and undertake strategic transactions. We continue to see and expect this “less is more” trend to mature in 2023.

M&A 59

M&A Mergers and Acquisitions Mergers Finance 59

Mergers and Inquisitions

JULY 31, 2024

Today, you could put most private equity activity in industrials into a few main categories: Consolidation / Roll-Up Plays – The idea is to acquire smaller companies to consolidate the parent company’s market position and become more appealing in an eventual IPO or M&A deal. To illustrate a simple deal, let’s use CD&R’s ~$2.6

Private Equity 66

Private Equity Equities Middle Market Debt 66

Cooley M&A

JANUARY 20, 2022

Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years. These players have looked further afield to add new capabilities and pipeline assets. DeSPAC transactions also hit an all? closing friction.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Mergers and Inquisitions

APRIL 10, 2024

This happened for a few reasons: 1) Soaring Valuations – Many sources say that sports team valuations “outperformed” the S&P 500 over the past 20 years, which is a polite way of saying that many teams are now valued at extremely high multiples. But its sales were growing briskly, with 20 – 25% growth in the two previous years.

Private Equity 103

Private Equity Equities Funds Entertainment 103

Cooley M&A

FEBRUARY 1, 2024

Private equity slowed but not stopped by financing environment Despite record amounts of dry powder accumulating for sponsors, high financing costs, persistent valuation gaps and a closed tech IPO market led to a significant decrease in private equity M&A activity in 2023.

M&A 59

M&A Mergers and Acquisitions Private Equity Equities 59

Cooley M&A

JANUARY 25, 2023

However, deal activity fizzled in the second half of 2022, as high inflation, aggressive anti-inflation monetary policies, geopolitical instability, assertive antitrust regulators and tightening financing markets depressed target valuations, reduced strategic acquirer confidence and sidelined private equity sponsor buyers. trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Focus Investment Banking

NOVEMBER 18, 2024

If you are not aware of the fundamental private equity model, it is simple: buy (or invest in) a company, grow profits through increasing sales, cutting costs and/or add-on acquisitions, and then sell the larger, more profitable company for significantly more than it was purchased for.

Private Equity 52

Private Equity Equities IPO Valuation 52

Mergers and Inquisitions

MARCH 5, 2025

In technology, as a startup keeps raising capital, it normally does so at gradually higher valuations as its customers, users, and revenue grow. But in biotech, companies valuations often remain close to their total capital raised until much later in the process (i.e., Short LQDA, Long UTHR: This works if you have the opposite view.

Funds 64

Funds Healthcare Mergers and Acquisitions Valuation 64

Mergers and Inquisitions

NOVEMBER 20, 2024

Reference any deals you’ve worked on that required analysis of these points and talk about how they affected the valuation or client’s decisions (this is more grounded than just saying, “I like high-growth companies!”). To add a growth equity spin, you can talk about wanting to understand operations and unit economics to evaluate companies.

Private Equity 59

Private Equity Equities Capital Valuation 59

Focus Investment Banking

FEBRUARY 11, 2025

Traditional terminal exit routes for private equity-backed companies are to larger strategic acquirers (often public companies) and IPOs, where a private company becomes publicly traded. It is also likely that IPOs will come to PPM, perhaps first to those specialties with the largest assets (e.g.,

Private Equity 52

Private Equity Healthcare Equities Medical 52

Cooley M&A

JANUARY 22, 2025

By 2030, more than 190 commercial drugs will lose patent exclusivity , putting at risk $236 billion in Big Pharma sales. This approach, combining M&A and initial public offering (IPO) preparations on parallel tracks, allows companies to maximize optionality in an uncertain market.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64

Cooley M&A

FEBRUARY 15, 2017

Dealmakers appear much more optimistic in the first quarter of 2017 than at this same time last year, in part because of greater optimism about the IPO market and the potential for favorable corporate tax and other regulatory changes. We expect this trend to continue, with mid-market and smaller deals driving the deal count in 2017.

M&A 40

M&A IPO Pharmaceutical Valuation 40